THE IMPACT OF ALCOHOL AND OTHER PSYCHOACTIVE SUBSTANCE USE DURING THE COVID19 PANDEMIC: PROBLEMS AND CONSEQUENCES

Abstract


This article discusses issues related to the use of surfactants during the COVID-19 pandemic. The global nature of this crisis has had a significant impact on the lives of people around the world, including their mental health. The introduction of quarantine and «isolation» measures have become one of the measures to control the spread of the disease, but such restrictions have led to various adverse psychological reactions such as anxiety, depression, post-traumatic stress disorder, as well as cases of self-mutilation and even suicide. All of these factors can negatively affect other aspects of health and lead to increased use of alcohol and other psychoactive substances. Stress, social isolation, the unpredictability of the future, loss of a job or income — all these can be motivating factors for people to turn to alcohol or other substances in search of relaxation or emotional support. However, such strategies are short-term and irrational, since alcohol consumption only worsens the mental state and further increases the risk of developing mental problems.

About the authors

D. H.-D. Khubieva

Stavropol State Medical University, 355017, Stavropol, Russia

K. R. Amlaev

Stavropol State Medical University, 355017, Stavropol, Russia

V. N. Mazharov

Stavropol State Medical University, 355017, Stavropol, Russia

O. O. Kravchenko

Stavropol State Medical University, 355017, Stavropol, Russia

V. B. Zafirova

Stavropol State Medical University, 355017, Stavropol, Russia

References

  1. Clay J. M., Parker M. O. Alcohol use and misuse during the COVID-19 pandemic: a potential public health crisis? // Lancet Public Health. 2020. Vol. 5, N 5. P. e259. doi: 10.1016/S24682667(20)30088-8
  2. Rogers A. H., Shepherd J. M., Garey L., Zvolensky M. J. Psychological factors associated with substance use initiation during the COVID-19 pandemic // Psychiatry Res. 2020. Vol. 293. P. 113407. doi: 10.1016/j.psychres.2020.113407
  3. Czeisler M. É., Lane R. I., Petrosky E. et al. Mental health, substance use, and suicidal ideation during the COVID-19 pandemic—United States, June 24–30, 2020 // Morb. Mortal. Wkly. Rep. 2020. Vol. 69, N 32. P. 1049–1057. doi: 10.15585/mmwr.mm6932a1
  4. Lapeyre-Mestre M., Boucher A., Daveluy A. et al. Addictovigilance contribution during COVID-19 epidemic and lockdown in France // Therapies. 2020. Vol. 75, N 4. P. 343–354. doi: 10.1016/j.therap.2020.06.006
  5. Ornell F., Moura H. F., Scherer J. N. et al. The COVID-19 pandemic and its impact on substance use: implications for prevention and treatment // Psychiatry Res. 2020. Vol. 289. P. 113096. doi: 10.1016/j.psychres.2020.113096
  6. Vecchio S., Ramella R., Drago A. et al. COVID-19 pandemic and people with opioid use disorder: innovation to reduce risk // Psychiatry Res. 2020. Vol. 289. P. 113047. doi: 10.1016/j.psychres.2020.113047
  7. Dubey S., Biswas P., Ghosh R. et al. Psychosocial impact of COVID-19 // Diabetes Metab. Syndr. Clin. Res. Rev. 2020. Vol. 14, N 5. P. 779–788. doi: 10.1016/j.dsx.2020.05.035
  8. Lynch F. L., Peterson E. L., Lu C. Y. et al. Substance use disorders and risk of suicide in a general US population: a case control study // Addict. Sci. Clin. Prac. 2020. Vol. 15, N 1. P. 14. doi: 10.1186/s13722-020-0181-1
  9. Ahmed M. Z., Ahmed O., Aibao Z. et al. Epidemic of COVID-19 in China and associated psychological problems // Asian J. Psychiatry. 2020. Vol. 51. P. 102092. doi: 10.1016/j.ajp.2020.102092.
  10. Knell G., Robertson M. C., Dooley E. E. et al. Health behavior changes during COVID-19 pandemic and subsequent «stay-athome» orders // Int. J. Environ. Res. Public Health. 2020. Vol. 17, N 17. P. 6268. doi: 10.3390/ijerph17176268
  11. Romero-Blanco C., Rodríguez-Almagro J., Onieva-Zafra M. D. et al. Physical activity and sedentary lifestyle in university students: changes during confinement due to the COVID-19 pandemic // Int. J. Environ. Res. Public Health. 2020. Vol. 17, N 18. P. 6567. doi: 10.3390/ijerph17186567
  12. Chodkiewicz J., Talarowska M., Miniszewska J. et al. Alcohol consumption reported during the COVID-19 pandemic: the initial stage // Int. J. Environ. Res. Public Health. 2020. Vol. 17, N 13. P. 4677. doi: 10.3390/ijerph17134677
  13. Newby J., O’Moore K., Tang S. et al. Acute mental health responses during the COVID-19 pandemic in Australia // PLoS ONE. 2020. Vol. 15, N 7. P. e0236562. doi: 10.1371/journal.pone.0236562
  14. Gritsenko V., Skugarevsky O., Konstantinov V. et al. COVID 19 fear, stress, anxiety, and substance use among Russian and Belarusian University students // Int. J. Ment. Health Addict. 2021. Vol. 19, N 6. P. 2362–2368. doi: 10.1007/s11469-020-00330-z
  15. Silczuk A. Threatening increase in alcohol consumption in physicians quarantined due to coronavirus outbreak in Poland: the ALCOVID survey // J. Public Health. 2020. Vol. 42, N 3. P. 461–465. doi: 10.1093/pubmed/fdaa110
  16. Panno A., Carbone G. A., Massullo C. et al. COVID-19 related distress is associated with alcohol problems, social media and food addiction symptoms: insights from the italian experience during the lockdown // Front. Psychiatry. 2020. Vol. 11. P. 1314. doi: 10.3389/fpsyt.2020.577135
  17. Håkansson A. Impact of COVID-19 on online gambling — a general population survey during the pandemic // Front. Psychology. 2020. Vol. 11. P. 568543. doi: 10.3389/fpsyg.2020.568543
  18. Đogaš Z., Kalcina L. L., Dodig I. P. et al. The effect of COVID-19 lockdown on lifestyle and mood in Croatian general population: a cross-sectional study // Croat. Med. J. 2020. Vol. 61, N 4. P. 309–318. doi: 10.3325/cmj.2020.61.309
  19. Grigoletto V., Cognigni M., Occhipinti A. A. et al. Rebound of severe alcoholic intoxications in adolescents and young adults after CoViD-19 lockdown // J. Adol. Health. 2020. Vol. 67, N 5. P. 727–729. doi: 10.1016/j.jadohealth.2020.08.017
  20. Leichtle S. W., Rodas E. B., Procter L. et al. The influence of a statewide “Stay-at-Home” order on trauma volume and patterns at a level 1 trauma center in the united states // Injury. 2020. Vol. 51, N 11. P. 2437–2441. doi: 10.1016/j.injury.2020.08.014
  21. Van Laar M. W., Oomen P. E., Van Miltenburg C. J., Vercoulen E., Freeman T. P., Hall W. D. Cannabis and COVID-19: reasons for concern // Front. Psychiatry. 2020. Vol. 11. P. 1419. doi: 10.3389/fpsyt.2020.601653
  22. Boehnke K. F., McAfee J., Ackerman J. M., Kruger D. J. Medication and substance use increases among people using cannabis medically during the COVID-19 pandemic // Int. J. Drug Policy. 2020. Vol. 92. P. 103053. doi: 10.1016/j.drugpo.2020
  23. Rodriguez L. M., Litt D. M., Stewart S. H. Drinking to cope with the pandemic: the unique associations of COVID-19-related perceived threat and psychological distress to drinking behaviors in American men and women // Addict. Behav. 2020. Vol. 110. P. 106532. doi: 10.1016/j.addbeh.2020.106532
  24. Sallie S. N., Ritou V., Bowden-Jones H., Voon V. Assessing international alcohol consumption patterns during isolation from the COVID-19 pandemic using an online survey: highlighting negative emotionality mechanisms // BMJ Open. 2020. Vol. 10, N 11. P. e044276. doi: 10.1136/bmjopen-2020-044276
  25. Vanderbruggen N., Matthys F., Van Laere S. et al. Self-reported alcohol, tobacco, and Cannabis use during COVID-19 lockdown measures: results from a web-based survey // Eur. Addict. Res. 2020. Vol. 26, N 6. P. 309–315. doi: 10.1159/000510822
  26. Wardell J. D., Kempe T., Rapinda K. K. et al. Drinking to cope during COVID‐19 pandemic: the role of external and internal factors in coping motive pathways to alcohol use, solitary drinking, and alcohol problems // Alcohol. Clin. Exp. Res. 2020. Vol. 44, N 10. P. 2073–2083. doi: 10.1111/acer.14425
  27. McPhee M. D., Keough M. T., Rundle S. et al. Depression, environmental reward, coping motives and alcohol consumption during the COVID-19 pandemic // Front. Psychiatry. 2020. Vol. 11. P. 1128. doi: 10.3389/fpsyt.2020.574676
  28. Kim J. U., Majid A., Judge R. et al. Effect of COVID-19 lockdown on alcohol consumption in patients with pre-existing alcohol use disorder // Lancet Gastroenterol. Hepatol. 2020. Vol. 5, N 10. P. 886–887. doi: 10.1016/S2468-1253(20)30251-X
  29. Dumas T. M., Ellis W., Litt D. M. What does adolescent substance use look like during the COVID-19 pandemic? examining changes in frequency, social contexts, and pandemic-related predictors // J. Adol. Health. 2020. Vol. 67, N 3. P. 354–361. doi: 10.1016/j.jadоhealth.2020.06.018
  30. Ballivian J., Alcaide M. L., Cecchini D. et al. Impact of COVID-19-related stress and lockdown on mental health among people living with HIV in Argentina // J. Acquired Immune Defic. Syndr. 2020. Vol. 85, N 4. P. 475–482. doi: 10.1097/QAI.0000000000002493
  31. Hawke L. D., Barbic S., Voineskos A. et al. Impacts of COVID-19 on youth mental health, substance use, and wellbeing: a rapid survey of clinical and community samples // Can. J. Psychiatry. 2020. Vol. 65. P. 701–709. doi: 10.1177/0706743720940562
  32. Martinotti G., Alessi M. C., Di Natale C. et al. Psychopathological burden and quality of life in substance users during the COVID-19 lockdown period in Italy // Front. Psychiatry. 2020. Vol. 11. P. 896. doi: 10.3389/fpsyt.2020.572245
  33. Rolland B., Haesebaert F., Zante E. et al. Global changes and factors of increase in caloric/salty food intake, screen use, and substance use during the early COVID-19 containment phase in the general population in france: survey study // JMIR Public Health Surveill. 2020. Vol. 6, N 3. doi: 10.2196/19630
  34. Sanchez T. H., Zlotorzynska M., Rai M., Baral S. D. Characterizing the impact of COVID-19 on men who have sex with men across the United States in April, 2020 // AIDS Behav. 2020. Vol. 24, N 7. P. 2024–2032. doi: 10.1007/s10461-020-02894-2
  35. Glober N., Mohler G., Huynh P. et al. Impact of COVID-19 pandemic on drug overdoses in Indianapolis // J. Urban Health. 2020. Vol. 97, N 6. P. 802–807. doi: 10.1007/s11524-020-00484-0
  36. Marais C., Soderstrom J., Fatovich D. Comparison of illicit drug‐related presentations to the emergency department: Pre‐COVID versus COVID // Emerg. Med. Australas. 2020. Vol. 32, N 5. P. 901–901. doi: 10.1111/1742-6723.13597
  37. Ochalek T. A., Cumpston K. L., Wills B. K. et al. Nonfatal opioid overdoses at an urban emergency department during the COVID-19 pandemic // JAMA. 2020. Vol. 324, N 16. P. 1673–1674. doi: 10.1001/jama.2020.17477
  38. Slavova S., Rock P., Bush H. M. et al. Signal of increased opioid overdose during COVID-19 from emergency medical services data // Drug Alcohol Depend. 2020. Vol. 214. P. 108176. doi: 10.1016/j.drugalcdep.2020.108176
  39. Lechner W. V., Laurene K. R., Patel S. et al. Changes in alcohol use as a function of psychological distress and social support following COVID-19 related University closings // Addict. Behav. 2020. Vol. 110. P. 106527. doi: 10.1016/j.addbeh.2020.106527
  40. Wang Y., Lu H., Hu M. et al. Alcohol consumption in China before and during CoViD-19: preliminary results from an online retrospective survey // Front. Psychiatry. 2020. Vol. 11. P. 597826. doi: 10.3389/fpsyt.2020.597826
  41. Yazdi K., Fuchs-Leitner I., Rosenleitner J., Gerstgrasser N. W. Impact of the COVID-19 pandemic on patients with alcohol use disorder and associated risk factors for relapse // Front. Psychiatry. 2020. Vol. 11. P. 1470. P. 620612. doi: 10.3389/fpsyt.2020.620612
  42. Vidot D. C., Islam J. Y., Camacho-Rivera M. et al. The COVID-19 cannabis health study: results from an epidemiologic assessment of adults who use cannabis for medicinal reasons in the United States // J. Addict. Dis. 2021. Vol. 39, N 1. P. 26–36. doi: 10.1080/10550887.2020.1811455

Statistics

Views

Abstract - 0

PDF (Russian) - 0

Cited-By


PlumX

Dimensions


Copyright (c) 1970 АО "Шико"

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Mailing Address

Address: 105064, Vorontsovo Pole, 12, Moscow

Email: ttcheglova@gmail.com

Phone: +7 903 671-67-12

Principal Contact

Tatyana Sheglova
Head of the editorial office
FSSBI «N.A. Semashko National Research Institute of Public Health»

105064, Vorontsovo Pole st., 12, Moscow


Phone: +7 903 671-67-12
Email: redactor@journal-nriph.ru

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies